Publications by authors named "Mario Melazzini"

Claim this Profile
O
Optimizing diagnostic outcomes and sustainability in radiological practices: a multicentric study on guideline adherence and incidental findings in elective chest CT scans.
Jacopo D'Argenzio, Andrea Esposito, Jacopo Pozzi, Caterina Giannitto, Massimo Zilocchi, Mario Giovanni Melazzini

Radiol Med· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New clinical insight in amyotrophic lateral sclerosis and innovative clinical development from the non-profit repurposing trial of the old drug guanabenz.
Anna Ambrosini, Eleonora Dalla Bella, Maddalena Ravasi, Mario Melazzini, Giuseppe Lauria

Front Med (Lausanne)· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The positive impact on translational research of Fondazione italiana di ricerca per la Sclerosi Laterale Amiotrofica (AriSLA), a non-profit foundation focused on amyotrophic lateral sclerosis. Convergence of ex-ante evaluation and ex-post outcomes when goals are set upfront.
Stefania Guareschi, Maddalena Ravasi, Danila Baldessari, Silvia Pozzi, Tiziana Zaffino, Mario Melazzini

Front Res Metr Anal· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I/IIa clinical trial of autologous hematopoietic stem cell transplantation in amyotrophic lateral sclerosis.
Christian Lunetta, Andrea Lizio, Corrado Cabona, Francesca Gerardi, Valeria Ada Sansone, Mario Giovanni Melazzini

J Neurol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Worldwide Effects of Coronavirus Disease Pandemic on Tuberculosis Services, January-April 2020.
Giovanni Battista Migliori, Pei Min Thong, Onno Akkerman, Jan-Willem Alffenaar, Fernando Álvarez-Navascués, Mario Melazzini

Emerg Infect Dis· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epidemic and pandemic viral infections: impact on tuberculosis and the lung: A consensus by the World Association for Infectious Diseases and Immunological Disorders (WAidid), Global Tuberculosis Network (GTN), and members of the European Society of Clinical Microbiology and Infectious Diseases Study Group for Mycobacterial Infections (ESGMYC).
Catherine Wei Min Ong, Giovanni Battista Migliori, Mario Raviglione, Gavin MacGregor-Skinner, Giovanni Sotgiu, Mario Giovanni Melazzini

Eur Respir J· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management and outcomes of post-acute COVID-19 patients in Northern Italy.
Michele Vitacca, Giovanni Battista Migliori, Antonio Spanevello, Mario Giovanni Melazzini, Nicolino Ambrosino

Eur J Intern Med· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Establishing the value of new drugs in Italy.].
Federico Villa, Claudio Jommi, Gianluca Altamura, Sara Antignani, Agnese Cangini, Mario Melazzini

Recenti Prog Med· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determinants of price negotiations for new drugs. The experience of the Italian Medicines Agency.
Federico Villa, Michaela Tutone, Gianluca Altamura, Sara Antignani, Agnese Cangini, Mario Melazzini

Health Policy· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[The ICD-ICF clinical model of hospital care].
Egidio Traversi, Isabella Springhetti, Mario Melazzini, Gianni Giorgi

G Ital Med Lav Ergon· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The new frontiers of rehabilitation medicine in people with chronic disabling illnesses.
Domenico Scrutinio, Anna Giardini, Luca Chiovato, Antonio Spanevello, Michele Vitacca, Mario Melazzini

Eur J Intern Med· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single nucleotide polymorphisms in angiogenesis-related genes and outcomes from antiangiogenic therapies in renal cell carcinoma: really a step towards personalized oncology, or not at all?
Camillo Porta, Laura Cosmai, Mimma Rizzo, Mario Melazzini

Ann Transl Med· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Forecasting Hepatitis C liver disease burden on real-life data. Does the hidden iceberg matter to reach the elimination goals?
Loreta A Kondili, Sarah Robbins, Sarah Blach, Ivane Gamkrelidze, Anna L Zignego, Mario Melazzini

Liver Int· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis.
Antonio Ascione, Massimo De Luca, Mario Melazzini, Simona Montilla, Maria Paola Trotta

Infection· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Italian compassionate use of sofosbuvir in HCV patients waitlisted for liver transplantation: A national real-life experience.
Silvia Martini, Maria Francesca Donato, Chiara Mazzarelli, Maria Rendina, Ubaldo Visco-Comandini, Mario Melazzini

Liver Int· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Italian compassionate use of sofosbuvir observational cohort study for the treatment of recurrent hepatitis C: clinical and virological outcomes.
Paola Carrai, Cristina Morelli, Gabriella Cordone, Antonietta Romano, Mariarosa Tamé, Mario Melazzini

Transpl Int· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intraclass differences in the risk of hospitalization for heart failure among patients with type 2 diabetes initiating a dipeptidyl peptidase-4 inhibitor or a sulphonylurea: Results from the OsMed Health-DB registry.
Gian Paolo Fadini, Stefania Saragoni, Pierluigi Russo, Luca Degli Esposti, Saula Vigili de Kreutzenberg, Mario Melazzini

Diabetes Obes Metab· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Amyotrophic Lateral Sclerosis Survival Score (ALS-SS): A simple scoring system for early prediction of patient survival.
Christian Lunetta, Andrea Lizio, Mario Giovanni Melazzini, Eleonora Maestri, Valeria A Sansone

Amyotroph Lateral Scler Frontotemporal Degener· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of advanced therapies in Italy: Management models and sustainability in six Italian cell factories.
Giuseppe Gaipa, Martino Introna, Josee Golay, Maria Luisa Nolli, Giuliana Vallanti, Mario Melazzini

Cytotherapy· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Strictly monitored exercise programs reduce motor deterioration in ALS: preliminary results of a randomized controlled trial.
Christian Lunetta, Andrea Lizio, Valeria A Sansone, Nadia Maria Cellotto, Eleonora Maestri, Mario Giovanni Melazzini

J Neurol· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aggressiveness, sexuality, and obsessiveness in late stages of ALS patients and their effects on caregivers.
Anna Marconi, Giulia Meloni, Federica Fossati, Christian Lunetta, Stefania Bastianello, Mario Melazzini

Amyotroph Lateral Scler· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Wide phenotypic spectrum of the TARDBP gene: homozygosity of A382T mutation in a patient presenting with amyotrophic lateral sclerosis, Parkinson's disease, and frontotemporal lobar degeneration, and in neurologically healthy subject.
Lorena Mosca, Christian Lunetta, Claudia Tarlarini, Francesca Avemaria, Eleonora Maestri, Mario Melazzini

Neurobiol Aging· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutation in the senataxin gene found in a patient affected by familial ALS with juvenile onset and slow progression.
Francesca Avemaria, Christian Lunetta, Claudia Tarlarini, Lorena Mosca, Eleonora Maestri, Mario Melazzini

Amyotroph Lateral Scler· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Repeated courses of granulocyte colony-stimulating factor in amyotrophic lateral sclerosis: clinical and biological results from a prospective multicenter study.
Adriano Chiò, Gabriele Mora, Vincenzo La Bella, Claudia Caponnetto, Gianluigi Mancardi, Mario Melazzini

Muscle Nerve· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consistent bone marrow-derived cell mobilization following repeated short courses of granulocyte-colony-stimulating factor in patients with amyotrophic lateral sclerosis: results from a multicenter prospective trial.
Corrado Tarella, Sergio Rutella, Francesca Gualandi, Mario Melazzini, Rosanna Scimè

Cytotherapy· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis